Sapna P Patel - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Sapna P Patel

Showing results (121-130 of 126) with videos related to

Pageof 13

Sort By:

You have reached the last page of results.This site can display upto 126 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2018

Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical OutcomeMarie-Andrée Forget, Cara Haymaker, Kenneth R Hess, et al.

Cancers|January 10, 2026

Metastatic Uveal Melanoma Surveillance: A Delphi Panel ConsensusJuan Alban, R Christopher Bowen, David A Reichstein, et al.

NPJ Genomic Medicine|August 19, 2017

Genomic and immune heterogeneity are associated with differential responses to therapy in melanomaAlexandre Reuben, Christine N Spencer, Peter A Prieto, et al.

The New England Journal of Medicine|March 1, 2023

Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced MelanomaSapna P Patel, Megan Othus, Yuanbin Chen, et al.

Nature Medicine|July 9, 2021

Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockadeMiles C Andrews, Connie P M Duong, Vancheswaran Gopalakrishnan, et al.

Science (New York, N.Y.)|December 23, 2021

Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy responseChristine N Spencer, Jennifer L McQuade, Vancheswaran Gopalakrishnan, et al.

Pageof 13

Search research articles

Showing results (121-130 of 126) with videos related to

Sort By:

Pageof 13

You have reached the last page of results.This site can display upto 126 results.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2018

Cancers|January 10, 2026

Metastatic Uveal Melanoma Surveillance: A Delphi Panel ConsensusJuan Alban, R Christopher Bowen, David A Reichstein, et al.

NPJ Genomic Medicine|August 19, 2017

Genomic and immune heterogeneity are associated with differential responses to therapy in melanomaAlexandre Reuben, Christine N Spencer, Peter A Prieto, et al.

The New England Journal of Medicine|March 1, 2023

Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced MelanomaSapna P Patel, Megan Othus, Yuanbin Chen, et al.

Nature Medicine|July 9, 2021

Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockadeMiles C Andrews, Connie P M Duong, Vancheswaran Gopalakrishnan, et al.

Science (New York, N.Y.)|December 23, 2021

Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy responseChristine N Spencer, Jennifer L McQuade, Vancheswaran Gopalakrishnan, et al.

Pageof 13